Markets

Health Care Sector Update for 02/13/2017: OMED

A generic image of money and a calculator
Credit: Shutterstock photo

Top Health-care stocks:

JNJ: +0.4%

PFE: flat

ABT: +0.9%

MRK: flat

AMGN: flat

Health-care shares were mainly unchanged in pre-market trade on Monday.

In health-care stocks news, OncoMed Pharmaceuticals ( OMED ) has enrolled and dosed the first patient in a phase 1b clinical trial of its anti-DLL4/VEGF bispecific antibody in combination with paclitaxel in patients with platinum-resistant ovarian cancer.

Shares in the company were unchanged at $8.27 pre-bell. The stock has traded between $7.41 and $15.49 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

US Markets

Latest Markets Videos